199 related articles for article (PubMed ID: 9608886)
1. Innovative and economic potential of mammalian cell culture.
Werner RG
Arzneimittelforschung; 1998 Apr; 48(4):423-6. PubMed ID: 9608886
[TBL] [Abstract][Full Text] [Related]
2. Appropriate mammalian expression systems for biopharmaceuticals.
Werner RG; Noé W; Kopp K; Schlüter M
Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718
[TBL] [Abstract][Full Text] [Related]
3. Mammalian cell cultures. Part II: Genetic engineering, protein glycosylation, fermentation and process control.
Werner RG; Noé W
Arzneimittelforschung; 1993 Nov; 43(11):1242-9. PubMed ID: 8292072
[TBL] [Abstract][Full Text] [Related]
4. Impact of cell culture process changes on endogenous retrovirus expression.
Brorson K; De Wit C; Hamilton E; Mustafa M; Swann PG; Kiss R; Taticek R; Polastri G; Stein KE; Xu Y
Biotechnol Bioeng; 2002 Nov; 80(3):257-67. PubMed ID: 12226857
[TBL] [Abstract][Full Text] [Related]
5. Advances in antibody manufacturing using mammalian cells.
Morrow KJ
Biotechnol Annu Rev; 2007; 13():95-113. PubMed ID: 17875475
[TBL] [Abstract][Full Text] [Related]
6. Process economics of industrial monoclonal antibody manufacture.
Farid SS
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):8-18. PubMed ID: 16899415
[TBL] [Abstract][Full Text] [Related]
7. Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing.
Trexler-Schmidt M; Sargis S; Chiu J; Sze-Khoo S; Mun M; Kao YH; Laird MW
Biotechnol Bioeng; 2010 Jun; 106(3):452-61. PubMed ID: 20178122
[TBL] [Abstract][Full Text] [Related]
8. Mammalian cell cultures. Part III: Safety and future aspects.
Werner RG; Noé W
Arzneimittelforschung; 1993 Dec; 43(12):1388-90. PubMed ID: 8141832
[TBL] [Abstract][Full Text] [Related]
9. Antibody production.
Birch JR; Racher AJ
Adv Drug Deliv Rev; 2006 Aug; 58(5-6):671-85. PubMed ID: 16822577
[TBL] [Abstract][Full Text] [Related]
10. Bioreactor and process design for large-scale mammalian cell culture manufacturing.
Nelson KL; Geyer S
Bioprocess Technol; 1991; 13():112-43. PubMed ID: 1367130
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in large-scale production of monoclonal antibodies and related proteins.
Shukla AA; Thömmes J
Trends Biotechnol; 2010 May; 28(5):253-61. PubMed ID: 20304511
[TBL] [Abstract][Full Text] [Related]
12. Suspension culture of mammalian cells.
Birch JR; Arathoon R
Bioprocess Technol; 1990; 10():251-70. PubMed ID: 1367062
[TBL] [Abstract][Full Text] [Related]
13. Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells.
Galbraith DJ; Tait AS; Racher AJ; Birch JR; James DC
Biotechnol Prog; 2006; 22(3):753-62. PubMed ID: 16739959
[TBL] [Abstract][Full Text] [Related]
14. Optimal and consistent protein glycosylation in mammalian cell culture.
Hossler P; Khattak SF; Li ZJ
Glycobiology; 2009 Sep; 19(9):936-49. PubMed ID: 19494347
[TBL] [Abstract][Full Text] [Related]
15. Stable production of a human growth hormone antagonist from CHO cells adapted to serum-free suspension culture.
Haldankar R; Kopchick JJ; Ridgway D
Biotechnol Prog; 1999; 15(3):336-46. PubMed ID: 10356250
[TBL] [Abstract][Full Text] [Related]
16. A systematic approach for scale-down model development and characterization of commercial cell culture processes.
Li F; Hashimura Y; Pendleton R; Harms J; Collins E; Lee B
Biotechnol Prog; 2006; 22(3):696-703. PubMed ID: 16739951
[TBL] [Abstract][Full Text] [Related]
17. Prediction of cell culture media performance using fluorescence spectroscopy.
Ryan PW; Li B; Shanahan M; Leister KJ; Ryder AG
Anal Chem; 2010 Feb; 82(4):1311-7. PubMed ID: 20088547
[TBL] [Abstract][Full Text] [Related]
18. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
[TBL] [Abstract][Full Text] [Related]
19. Bioseparation in antibody manufacturing: the good, the bad and the ugly.
Gottschalk U
Biotechnol Prog; 2008; 24(3):496-503. PubMed ID: 18442255
[TBL] [Abstract][Full Text] [Related]
20. Production of recombinant proteins in suspension-cultured plant cells.
Plasson C; Michel R; Lienard D; Saint-Jore-Dupas C; Sourrouille C; de March GG; Gomord V
Methods Mol Biol; 2009; 483():145-61. PubMed ID: 19183898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
